China Resources Boya Bio-pharmaceutical Group's stock price ...
China Resources Boya Bio-pharmaceutical Group's stock price continues to drop despite healthier EPS and revenue growth, indicating a market readjustment of previous high expectations and possible influence of market uncertainties.
Earnings Are Growing at China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) but Shareholders Still Don't Like Its Prospects
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment